Aarhus University Seal / Aarhus Universitets segl

Michael Etzerodt

Associate professor

Curriculum Vitae

C.V. for Michael Etzerodt

 

Education

1988              Ph. D. in molecular biology, University of Aarhus, Denmark

1982              M. sc. in Microbiology & Chemistry, University of Aarhus, Denmark

  

  

Employments

2014 -            Teaching coordinator, bachelor- and master educations i molecular biology. Head of teaching committee

2007 -  2008   Sabbatical (University of Aarhus)

2001 -  2008   Scientific Officer, Borean Pharma A/S

1996-             Associate Professor, Department of Molecular Biology, University of Aarhus. From 2002 to 2006 University of Aarhus was reimbursed, in part, for my salary, allowing me also to work for Borean Pharma A/S.

1989-1996      Assistant & assoc. research professor, Department of Molecular Biology, University of Aarhus

1988-1989      Post. Doc., Department of Molecular Biology, University of Aarhus

1986-1988      Visiting Scientist (EMBO Long-Term Fellowship), European Molecular Biology Laboratory EMBL (Director's Laboratory), Heidelberg, FRG

1983-1986      Junior Research Fellowship, Danish Cancer Society, Department of Molecular Biology, University of Aarhus

1982              Research assistant, Department of Molecular Biology, University of Aarhus

 

  

Industry Relations

2002              Founder Etze Holding ApS

2001              Senior Vice President - Strategy & Operations, Borean Pharma A/S

1997              Co-founder of Borean Pharma A/S

1993              Co-founder of Denzyme ApS

1991              Co-founder of Kebitek Holding ApS and Kebitek ApS

 

  

Major Commercial Milestones

2007              Sold Borean technology platform and projects (IP and materials) to 5am venture

2006              Sold drug candidate to F. Hoffmann-La Roche, resp. for project transfer

2004 - 5         Series B funding (15M €) of Borean Pharma A/S by Danish and International biotech venture.

2001              Series A funding (10M €) of Borean Pharma A/S by Danish biotech venture

1996              Sold Denzyme ApS (technology to improve recombinant fusion protein engineering) to Cambridge antibody Technology ltd. (CaT)

1991              Sold thermocycling technology & equipment for PCR processes to Hybaid ltd. (UK)